Tectonic Therapeutic (TECX) Change in Account Payables (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Change in Account Payables of $1.4 million for Q1 2026, down 12.69% year-over-year from $1.6 million in Q1 2025, and up 503.21% quarter-over-quarter from -$343000.0 in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Change in Account Payables (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Change in Account Payables for 10 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 12.69% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at -$85000.0 (up 93.69% YoY), while the FY2025 annual figure was $116000.0, up 108.16% from the prior year.
- Change in Account Payables climbed to $1.4 million in Q1 2026 per TECX's latest filing, from -$343000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.3 million in Q3 2023 and bottomed at -$4.2 million in Q4 2023.
- Historically, Change in Account Payables has averaged -$187588.2 across 5 years, with a median of $137000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 2219.23% — and 2025, when it plunged 1567.44%.
- Tectonic Therapeutic's Change in Account Payables stood at -$1.4 million in 2022, then tumbled by 192.59% to -$4.2 million in 2023, then jumped by 65.65% to -$1.4 million in 2024, then jumped by 76.13% to -$343000.0 in 2025, then jumped by 503.21% to $1.4 million in 2026.
- Business Quant data shows TECX's Change in Account Payables at $1.4 million in Q1 2026, -$343000.0 in Q4 2025, and -$1.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | -799,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -799,000.00 |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | -343,000.00 |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | 137,000.00 |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Sep 30, 2024 | 86,000.00 |
| Jun 30, 2024 | -1.58 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | -4.18 Mn |
| Sep 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 207,000.00 |
| Dec 31, 2022 | -1.43 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | -4.01 Mn |
| Mar 31, 2022 | 551,000.00 |
| Dec 31, 2021 | 520,000.00 |
| Sep 30, 2021 | 937,000.00 |